In addition, the demethylating activity of AZA is also extended to MSCs: AZA treatment induces demethylation and thus increases the expression of SPINT2/HAI-2, which is methylated and silenced in MDSss and AML [121]. This evidence concerns the gene SPINT2 and acute myeloid leukemia.